Business description
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.
Management board & Supervisory board
| CEO |
| Hervé Hoppenot |
| Management board |
| Christiana Stamoulis, Barry P. Flannelly, Dr. Dashyant Dhanak, Dr. Lothar H. Finke, Jonathan E. Dickinson, Maria E. Pasquale, Michael Morrissey, Paula J. Swain, Steven H. Stein, M.D., Vijay Iyengar, M.D., Denise Brashear, Xiaozhao Wang, Pablo J. Cagnoni |
| Supervisory board |
| Hervé Hoppenot, Dr. Jacqualyn A. Fouse, Edmund P. Harrigan, M.D., Jean-Jacques Bienaimé, Julian C. Baker, Katherine High, M.D., Otis Brawley, M.D., Paul J. Clancy, Susanne Schaffert |
Company data
| Name: |
Incyte Corporation |
| Address: |
1801 Augustine Cut-Off,Wilmington, DE 19803, USA |
| Phone: |
+1-302-498-6700 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.incyte.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12/31 |
| Free Float: |
41.80% |
| IPO date: |
- |
Investor relations
| Name: |
Greg Shertzer |
| IR phone: |
+1-302-274-4779 |
| IR Fax: |
- |
| IR e-mail: |
gshertzer@incyte.com
|